Diagnostic Significance of Serum IgG Galactosylation in CA19-9-Negative Pancreatic Carcinoma Patients

Background: Although Carbohydrate antigen 19-9 (CA19-9) is considered clinically useful and informative for pancreatic carcinoma (PC), false positive results, and false negative results have restricted its clinical use. Especially missed or delayed diagnosis of PC patients with negative CA19-9 value...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Ailing, Qin, Ruihuan, Qin, Wenjun, Han, Jing, Gu, Yong, Zhou, Lei, Zhang, Hongqin, Ren, Shifang, Lu, Renquan, Guo, Lin, Gu, Jianxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402387/
https://www.ncbi.nlm.nih.gov/pubmed/30873386
http://dx.doi.org/10.3389/fonc.2019.00114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402387/
https://www.ncbi.nlm.nih.gov/pubmed/30873386
http://dx.doi.org/10.3389/fonc.2019.00114

Ejemplares similares